Research Article
Preoperative Serum Levels of Mesothelin in Patients with Colon Cancer
Table 2
Preoperative serum mesothelin levels of the clinicopathologic variables of the patients (mean ± SD) (minimum–maximum) were indicated.
| | Mesothelin (pg/mL) |
| Tumor size | | ≤3 cm | 5.02 ± 2.7 (1–9) | >3 cm | 10.86 ± 2.42 (8–16) | TNM stage | | TI | 3.4 ± 2.3 (1–8) | TII | 6.0 ± 1.7 (3–9) | TIII | 9.29 ± 1.8 (6–15) | TIV | 12.09 ± 2.03 (9–16) | Invasion | | T1 | 3.11 ± 2.22 (1–8) | T2 | 5.72 ± 10.56 (3–9) | T3 | 8.89 ± 1.19 (6–11) | T4 | 12.19 ± 2.04 (9–16) | Lymph node metastasis | | N0 | 4.19 ± 2.57 (1–9) | N1 | 6.72 ± 2.34 (3–11) | N2 | 11.02 ± 2.38 (6–16) | Metastasis | | Present | 9.81 ± 3.02 (3–16) | Not present | 3.73 ± 2.4 (1–8) |
|
|